Who invested in Acylin Therapeutics?
Acylin Therapeutics's investors include ARCH Venture Partners, Alexandria Real Estate Equities, OVP Venture Partners and Amgen.
United States · Series A startup
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$6.4Mraised across 2 rounds since 2011, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $2.0M sold, first sale May 2012
Reported by onbiovc.comSEC filing: $2.0M sold, first sale Nov 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Acylin Therapeutics's investors include ARCH Venture Partners, Alexandria Real Estate Equities, OVP Venture Partners and Amgen.
Acylin Therapeutics has raised $6.4M across 2 rounds since 2011.
Acylin Therapeutics's most recent round was a Series A of $2.0M in Jun 2012.
Acylin Therapeutics's largest round on record is $4.4M (Series A), in Jan 2011.
Acylin Therapeutics's first round on record, in Jan 2011, was backed by ARCH Venture Partners, Alexandria Real Estate Equities and OVP Venture Partners and 1 others.
Acylin Therapeutics's latest named round is a Series A, in Jun 2012.
Acylin Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.